Issue 9/2016
Content (10 Articles)
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer
Pieter T. de Boer, Geert W. J. Frederix, Talitha L. Feenstra, Pepijn Vemer
Cost Effectiveness of HPV Vaccination: A Systematic Review of Modelling Approaches
Joshua Pink, Ben Parker, Stavros Petrou
Economic Evaluations of Opioid Use Disorder Interventions
Sean M. Murphy, Daniel Polsky
Use of Intermediate Endpoints in the Economic Evaluation of New Treatments for Advanced Cancer and Methods Adopted When Suitable Overall Survival Data are Not Available
Catherine Beauchemin, Marie-Ève Lapierre, Nathalie Letarte, Louise Yelle, Jean Lachaine
The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence
James Lomas, Alexis Llewellyn, Marta Soares, Mark Simmonds, Kath Wright, Alison Eastwood, Stephen Palmer
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Stéphane Verguet, Jane J. Kim, Dean T. Jamison
Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland
Susanne Schmitz, Laura McCullagh, Roisin Adams, Michael Barry, Cathal Walsh
The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland
Lisa Nagy, Terho Heikkinen, Alfred Sackeyfio, Richard Pitman
Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting
Melanie J. Davies, Divina Glah, Barrie Chubb, Gerasimos Konidaris, Phil McEwan